Bottle X: Exposing Impurities in the Generic Drug Business

In June 2013, the U.S. Food and Drug Administration tappedĀ Altaf Lal, an American of Indian origin with sterling public-health credentials, to solve what appeared to be a diplomacy problem. The FDA's relations with Indian regulators were in tatters, one month after India's largest drug company, Ranbaxy, pleaded guilty to seven felonies related to falsifying quality